Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Consun Pharmaceutical (1681 HK)
Watchlist
30
Analysis
Health Care
•
China
Consun Pharmaceutical Group Limited is a pharmaceutical company engaged in the research, manufacturing and sale of modern Chinese medicines and medical contrast medium in the People's Republic of China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
China Traditional Chinese Medicine
•
08 May 2024 20:47
China Traditional Chinese Medicine (570 HK): Evaluating Deal-Break Risks
The wide gross spread (7.0%) reflects risks around the re-rating of peers, the slow pace of satisfying the pre-condition, the completion timetable...
Arun George
Follow
510 Views
Share
bullish
•
China Traditional Chinese Medicine
•
21 Feb 2024 23:19
China Traditional Chinese Medicine (570 HK): Sinopharm-Led Pre-Conditional Offer at HK$4.60
The offer is attractive to historical trading ranges and peer multiples. Ping An, which holds a blocking stake, will be supportive. This looks like...
Arun George
Follow
480 Views
Share
bullish
•
China Traditional Chinese Medicine
•
07 Feb 2024 22:14
China Traditional Chinese Med (570 HK): Third Time's the Charm as Sinopharm Revives Its Interest?
Due to Sinopharm's previous privatisation attempts, shareholders will be wary of the latest rumour. Nevertheless, the valuation is undemanding...
Arun George
Follow
362 Views
Share
bullish
•
Consun Pharmaceutical
•
23 May 2023 08:55
Consun Pharmaceutical (1681.HK) - Undervalued. Good Performance Growth Will Continue
The most intuitive information in 2022 report is that both revenue and profit of Consun had good growth, with stable dividend payout. Consun is...
Xinyao (Criss) Wang
Follow
345 Views
Share
bullish
•
Consun Pharmaceutical
•
07 Feb 2023 14:55
Consun Pharmaceutical (1681.HK) - Still Has Investment Value Even Without High-Priced Acquisition
The high-priced acquisition of Consun was terminated. However, Consun has solid business performance and its growth would continue this year. The...
Xinyao (Criss) Wang
Follow
354 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x